{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:53:15Z","timestamp":1761169995385,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000},"content-version":"vor","delay-in-days":2915,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/gim.2013.56","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T11:17:55Z","timestamp":1368703075000},"page":"983-989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa"],"prefix":"10.1016","volume":"15","author":[{"given":"Raphael","family":"Schiffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Blankenship","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe T.R.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Barshop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Rhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Fuller","key":"10.1038\/gim.2013.56_bb0010"},{"author":"Auray-Blais","key":"10.1038\/gim.2013.56_bb0015"},{"author":"Auray-Blais","key":"10.1038\/gim.2013.56_bb0020"},{"author":"Auray-Blais","key":"10.1038\/gim.2013.56_bb0025"},{"author":"Young","key":"10.1038\/gim.2013.56_bb0030"},{"author":"Togawa","key":"10.1038\/gim.2013.56_bb0035"},{"author":"Schiffmann","key":"10.1038\/gim.2013.56_bb0040"},{"author":"Vedder","key":"10.1038\/gim.2013.56_bb0045"},{"author":"Katz","key":"10.1038\/gim.2013.56_bb0050"},{"key":"10.1038\/gim.2013.56_bb0055","unstructured":"Center for Drug Evaluation and Research (CDER), Food and Drug Administration, U.S. Department of Health and Human Services. Guidance for Industry - qualification process for drug development tools. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM230597.pdf. Accessed 21 November 2012."},{"author":"West","key":"10.1038\/gim.2013.56_bb0060"},{"author":"Schiffmann","key":"10.1038\/gim.2013.56_bb0065"},{"author":"Hughes","key":"10.1038\/gim.2013.56_bb0070"},{"author":"CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)","key":"10.1038\/gim.2013.56_bb0075"},{"key":"10.1038\/gim.2013.56_bb0080","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","author":"K\/DOQI","year":"2002","journal-title":"Am J Kidney Dis"},{"author":"Schiffmann","key":"10.1038\/gim.2013.56_bb0085"},{"author":"Aerts","key":"10.1038\/gim.2013.56_bb0090"},{"key":"10.1038\/gim.2013.56_bb0095","series-title":"Fabry Disease: Perspectives From 5 Years of FOS","article-title":"Biomarkers in lysosomal storage diseases","author":"Cox","year":"2006"},{"author":"Grabowski","key":"10.1038\/gim.2013.56_bb0100"},{"author":"Ries","key":"10.1038\/gim.2013.56_bb0105"},{"author":"Aerts","key":"10.1038\/gim.2013.56_bb0110"},{"author":"Rombach","key":"10.1038\/gim.2013.56_bb0115"},{"author":"Fleming","key":"10.1038\/gim.2013.56_bb0120"},{"author":"Auray-Blais","key":"10.1038\/gim.2013.56_bb0125"},{"author":"Shen","key":"10.1038\/gim.2013.56_bb0130"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/gim201356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gim201356","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021026812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021026812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/gim201356.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:43:19Z","timestamp":1761097399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021026812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1098360021026812"],"URL":"https:\/\/doi.org\/10.1038\/gim.2013.56","relation":{},"ISSN":["1098-3600"],"issn-type":[{"type":"print","value":"1098-3600"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/gim.2013.56","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}